Find information on thousands of medical conditions and prescription drugs.

Fiorinal

Fiorinal is a combination analgesic medication consisting of acetylsalicylic acid, the barbiturate butalbital and caffeine. Some formulations also contain the opioid codeine. It is used to treat tension headaches and migraines. The mechanism of action is not well understood. Since butalbital is habit-forming, using fiorinal daily can lead to dependency. Fiorinal #3 contains: 30 mg codeine, 50 mg butalbital, 40 mg caffeine, and 325 mg aspirin. Used for severe dental pain (1-2 cap q4h prn).

Other brand names include Fiormor®, Fiortal®, Fortabs®, and Laniroif®.

Home
Diseases
Medicines
A
B
C
D
E
F
Captagon
Famohexal
Famotidine
Faslodex
Faslodex
Fasoracetam
Felbamate
Felbatol
Felodipine
Felypressin
Femara
Femara
Fempatch
Femring
Fenfluramine
Fenofibrate
Fentanyl
Fexofenadine
Filgrastim
Filipin
Finasteride
Fioricet
Fiorinal
Flagyl
Flarex
Flavoxate
Flecainide
Flexeril
Flomax
Flonase
Flovent
Floxuridine
Fluacizine
Flucloxacillin
Fluconazole
Flucytosine
Fludarabine
Fludrocortisone
Flumazenil
Flunisolide
Flunitrazepam
Fluocinonide
Fluohexal
Fluorometholone
Fluorouracil
Fluoxetine
Fluphenazine
Flurazepam
Flutamide
Fluticasone
Fluvastatin
Fluvoxamine
FML
Focalin
Folic acid
Follutein
Fomepizole
Formoterol
Fortamet
Fortovase
Fosamax
Fosinopril
Fosinoprilat
Fosmidomycin
Fosphenytoin
Frova
Frovatriptan
Frusehexal
Fulvestrant
Fumagillin
Furazolidone
Furosemide
Furoxone
Fusafungine
Fusidic acid
Fuzeon
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Read more at Wikipedia.org


[List your site here Free!]


Watson Pharmaceuticals' - Branded News - Brief Article
From Drug Store News, 3/23/03

The FDA last month approved Watson Pharmaceuticals' Oxytrol (oxybutynin transdermal system), a transdermal therapy to treat overactive bladder, a condition estimated to affect more than 33 million Americans. Oxytrol is a thin, flexible and clear patch that can be applied to the abdomen, hip or buttock twice weekly. Oxytrol's active ingredient, oxybutynin, has been prescribed as an oral formulation for the past 25 years.

In other news, Watson Pharmaceuticals last month completed its acquisition of the U.S. marketing rights to the Fioricet and Fiorinal product lines, both prescription treatments for migraine and tension headaches, or 178 million from Novartis. The products acquired include Fiorinal CIII (butalbital, aspirin and caffeine capsules), Fiorinal with codeine CIII, Fioricet (butalbital, acetaminophe and caffeine tablets) and Fioricet with codeine CIII.

COPYRIGHT 2003 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2003 Gale Group

Return to Fiorinal
Home Contact Resources Exchange Links ebay